Chemotherapy: IPC and HIPEC

This is our first episode in season 2 of RSGYO, which consists of shorter episodes on adjunctive topics. In this episode, we dive into the mechanisms of action of hormonal therapies, the biological rationale behind their use, and clinical scenarios highlighting how these agents a ...  Show more

This is the fourth of seven episodes covering ovarian cancer. In this episode, we discuss the management of recurrent, platinum-resistant epithelial ovarian cancer. Join us to explore the prognosis of PROC, recommendations for systemic chemotherapy, the role of bevacizumab, the u ...  Show more

Join experts Drs Kevin Kalinsky and Heather McArthur as they discuss the latest studies guiding their decisions when treating patients with TNBC in clinic. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarticle/991253). The ...  Show more

In our previous episode, we covered the revised FIGO ovarian cancer staging which now includes fallopian tube and peritoneal malignancies. In this episode, we will cover the FIGO guidelines regarding the management of OVFTP cancer. What role do PARP inhibitors play? Does treatmen ...  Show more

In this episode of PodMD, experienced sub-specialist Gynaecological Oncologist Dr Rhett Morton will be discussing the topic of ovarian cancer, including how a patient would typically present, the treatment options available, the warning signs to look out for, the likelihood of ...